// App-Quantinova.ai

: Comparing asthma and COPD inhaler devices in real life clinical practice in the UK: differences in training requirements and preference

Researchers

Presenter

  • Henry Chrystyn

Principal Investigators

  • Hicham Benhaddi

  • Marianka van der Tol

  • Jaco Voorham

  • John Haughney

  • Sinthia Bosnic-Anticevich

  • David Price

  • Nicholas Roche

Medical Centers

  • Inhalation Consultancy Ltd, Leeds, United Kingdom,

  • Teva Pharmaceuticals Europe B.V., Brussels, Belgium

  • Observational and Pragmatic Research Institute, Singapore, Singapore,

  • University of Aberdeen, Aberdeen, Scotland, United Kingdom

  • The University of Sydney, North Sydney, Australia

  • Hopitaux Universitaires Paris-Sud, Paris, France

Locations

  • United Kingdom

  • Belgium

  • Singapore

  • Australia

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Asthma

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • DuoResp Spiromax

  • Advair HFA

  • Symbicort

  • Salbutamol

Outcome

  • N/A

Study Design

  • Observational

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved